Suppr超能文献

来源于智利五月茶的 Celastroloids 对锥虫的敏感性。

Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis.

机构信息

Laboratorio de Investigación en Productos Naturales, Facultad de Química y Farmacia, Universidad de El Salvador, San Salvador, El Salvador.

Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna, La Laguna, Tenerife, Canary Islands, Spain.

出版信息

Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02236-20.

Abstract

Leishmaniasis and Chagas are among the most significant neglected tropical diseases. Due to several drawbacks with the current chemotherapy, developing new antikinetoplastid drugs has become an urgent issue. In the present work, a bioassay-guided investigation of the root bark of on and led to the identification of two -friedo-nor-oleanane triterpenoids (celastroloids), 20β-hydroxy-tingenone (celastroloid 5) and 3--methyl-6-oxo-tingenol (celastroloid 8), as promising antikinetoplastid leads. They displayed higher potency on promastigotes (50% inhibitory concentrations [ICs], 0.44 and 1.12 μM, respectively), intracellular amastigotes (ICs, 0.83 and 1.91 μM, respectively), and epimastigote stage (ICs, 2.61 and 3.41 μM, respectively) than reference drugs miltefosine and benznidazole. This potency was coupled with an excellent selectivity index on murine macrophages. Mechanism of action studies, including mitochondrial membrane potential (Δψm) and ATP-level analysis, revealed that celastroloids could induce apoptotic cell death in triggered by the mitochondria. In addition, the structure-activity relationship is discussed. These findings strongly underline the potential of celastroloids as lead compounds to develop novel antikinetoplastid drugs.

摘要

利什曼病和恰加斯病是最重要的被忽视热带病之一。由于目前化疗存在一些缺点,开发新的抗动基体药物已成为当务之急。在本工作中,对 和 的根皮进行了基于生物测定的研究,鉴定出两种 -friedo-降-齐墩果烷型三萜(Celastroloids),20β-羟基-卫矛酮(Celastroloid 5)和 3β-羟基-6-酮-卫矛醇(Celastroloid 8),它们是有前途的抗动基体先导化合物。它们对 前鞭毛体(50%抑制浓度 [ICs],分别为 0.44 和 1.12 μM)、内阿米巴体(ICs,分别为 0.83 和 1.91 μM)和 滋养体阶段(ICs,分别为 2.61 和 3.41 μM)的活性均高于参比药物米替福新和苯并咪唑。这种活性伴随着对鼠巨噬细胞的优异选择性指数。包括线粒体膜电位(Δψm)和 ATP 水平分析在内的作用机制研究表明,Celastroloids 可诱导 触发的细胞凋亡。此外,还讨论了构效关系。这些发现强烈地强调了 Celastroloids 作为开发新型抗动基体药物的潜在先导化合物的潜力。

相似文献

1
Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis.
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02236-20.
2
Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids.
Plants (Basel). 2024 Jan 25;13(3):360. doi: 10.3390/plants13030360.
3
Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
Eur J Med Chem. 2017 Mar 10;128:25-35. doi: 10.1016/j.ejmech.2017.01.029. Epub 2017 Jan 23.
4
Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death.
Biomed Pharmacother. 2023 Aug;164:114879. doi: 10.1016/j.biopha.2023.114879. Epub 2023 May 19.
7
Antiprotozoal activity of quinonemethide triterpenes from Maytenus ilicifolia (Celastraceae).
Molecules. 2013 Jan 15;18(1):1053-62. doi: 10.3390/molecules18011053.
9
Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
Eur J Med Chem. 2017 Oct 20;139:947-960. doi: 10.1016/j.ejmech.2017.08.055. Epub 2017 Sep 1.
10
Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action.
PLoS One. 2020 Nov 6;15(11):e0241855. doi: 10.1371/journal.pone.0241855. eCollection 2020.

引用本文的文献

1
Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound.
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1106. doi: 10.3390/ph18081106.
2
Bioprospecting for Anti-Kinetoplastid Drug Discovery from Essential Oil.
Int J Mol Sci. 2025 Jun 13;26(12):5697. doi: 10.3390/ijms26125697.
3
Mechanism Insight of Cell Death Signaling by Thymol Derivatives on Trypanosomatidae Protozoan Parasites.
Antibiotics (Basel). 2025 Apr 5;14(4):383. doi: 10.3390/antibiotics14040383.
4
Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound.
Pharmaceuticals (Basel). 2024 Apr 25;17(5):554. doi: 10.3390/ph17050554.
5
Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids.
Plants (Basel). 2024 Jan 25;13(3):360. doi: 10.3390/plants13030360.

本文引用的文献

1
Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge.
ACS Infect Dis. 2020 Nov 13;6(11):2830-2843. doi: 10.1021/acsinfecdis.0c00353. Epub 2020 Oct 9.
2
Sesquiterpenoids and flavonoids from Inula viscosa induce programmed cell death in kinetoplastids.
Biomed Pharmacother. 2020 Oct;130:110518. doi: 10.1016/j.biopha.2020.110518. Epub 2020 Jul 13.
3
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
4
Why hasn't there been more progress in new Chagas disease drug discovery?
Expert Opin Drug Discov. 2020 Feb;15(2):145-158. doi: 10.1080/17460441.2020.1681394. Epub 2019 Oct 31.
5
Withanolides from as Antikinetoplastid Agents through Induction of Programmed Cell Death.
Pathogens. 2019 Oct 1;8(4):172. doi: 10.3390/pathogens8040172.
6
Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins.
Eur J Med Chem. 2019 Dec 1;183:111687. doi: 10.1016/j.ejmech.2019.111687. Epub 2019 Sep 9.
8
SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway.
Eur J Med Chem. 2019 Sep 1;177:171-187. doi: 10.1016/j.ejmech.2019.05.009. Epub 2019 May 12.
10
Drug Discovery for Kinetoplastid Diseases: Future Directions.
ACS Infect Dis. 2019 Feb 8;5(2):152-157. doi: 10.1021/acsinfecdis.8b00298. Epub 2018 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验